iBio, Inc. (IBIO) — Financial statements
Income statement, balance sheet, and cash flow for iBio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.40↑77.8% | 0.23 | 0.00↓100.0% | 2↓20.5% | 2 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00↓100.0% | 4↑159.3% | 1 | |
| Gross Profit | 0.40↑77.8% | 0.23 | 0.00↑100.0% | -2↓309.8% | 0.91 | |
| Operating Expenses | ||||||
| R&D Expenses | 8↑60.3% | 5↓49.8% | 10↑5.1% | 10↓1.6% | 10 | |
| General & Administrative Expenses | 11↓8.4% | 12↓38.6% | 19 | 0.00↓100.0% | 22 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.19 | |
| SG&A Expenses | 11↓8.4% | 12↓38.6% | 19↑5.9% | 18↓17.9% | 22 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.14 | |
| Operating Expenses | 19↑12.7% | 17↓42.5% | 29↑5.6% | 28↓13.2% | 32 | |
| Total Costs & Expenses | 19↑12.7% | 17↓42.5% | 29↓7.1% | 32↓5.7% | 33 | |
| Operating Results | ||||||
| Operating Income | -19↓11.8% | -17↑43.3% | -29↑1.2% | -30↑4.5% | -31 | |
| Depreciation & Amortization | 1↓9.9% | 1↓9.4% | 1↓63.6% | 4↑57.0% | 2 | |
| EBITDA | -17↓21.5% | -14↑49.7% | -28↓8.3% | -26↑9.9% | -29 | |
| EBIT | -18↓19.0% | -15↑47.8% | -29↑1.0% | -30↑4.7% | -31 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.23↑17.8% | 0.19↑46.9% | 0.13↓26.6% | 0.18↑107.6% | -2 | |
| Interest Income | 0.44↑20.4% | 0.36↑179.2% | 0.13↓26.6% | 0.18↑26.4% | 0.14 | |
| Interest Expense | 0.21↑23.3% | 0.17 | 0.00 | 0.00↓100.0% | 2 | |
| Non-Operating Income | -0.44↑67.9% | -1↓1085.2% | -0.12↑37.5% | -0.18↓28.7% | -0.14 | |
| Other Income / Expenses | 0.23↓81.1% | 1↑3621.9% | 0.03↓82.6% | 0.18↓97.7% | 8 | |
| Income Before Tax | -18↓19.0% | -15↑47.3% | -29↑0.7% | -30↓27.1% | -23 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -18↓19.0% | -15↑47.3% | -29↑0.7% | -30↓27.1% | -23 | |
| Net Income from Discontinued Operations | 0.00↑100.0% | -9↑73.5% | -36↓71.7% | -21 | 0.00 | |
| Net Income | -18↑26.2% | -25↑61.7% | -65↓29.0% | -50↓117.1% | -23 | |
| Bottom-Line Net Income | -18↑26.2% | -25↑61.7% | -65↓29.0% | -50↓114.7% | -23 | |
| EPS (Basic) | -1.75↑73.1% | -6.50↑93.9% | -106.18↑96.3% | -2,889.06↓4716.7% | -59.98 | |
| EPS (Diluted) | -1.75↑73.1% | -6.50↑93.9% | -106.18↑96.3% | -2,889.06↓4716.7% | -59.98 | |
| Weighted Average Shares | 10↑174.1% | 4↑525.7% | 0.61↑3410.2% | 0.02↓95.5% | 0.39 | |
| Weighted Average Diluted Shares | 10↑174.1% | 4↑525.7% | 0.61↑3410.2% | 0.02↓95.5% | 0.39 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.